Nucleolin (NCL) is an RBP overexpressed in BC, and tRF3E derived from tRNA-Glu can form a complex with NCL, thereby disrupting the inhibitory effect of NCL on p53 mRNA translation, leading to increased p53 expression and thus inhibiting tumor growth.147. The gene discussed is NUCLEOLIN; the disease is breast cancer.